Zeng ZC - Search Results

1

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation.

He J, Zeng ZC, Fan J, Zhou J, Sun J, Chen B, Yang P, Wang BL, Zhang BH, Zhang JY. He J, et al. Among authors: zeng zc. BMC Cancer. 2011 Nov 22;11:492. doi: 10.1186/1471-2407-11-492. BMC Cancer. 2011. PMID: 22107882 Free PMC article.

2

Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion.

Zeng ZC, Tang ZY, Liu KD, Lu JZ, Cai XJ, Xie H. Zeng ZC, et al. Cancer Immunol Immunother. 1994 Nov;39(5):332-6. doi: 10.1007/BF01519987. Cancer Immunol Immunother. 1994. PMID: 7987865 Free PMC article.

3

Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.

Zeng ZC, Tang ZY, Xie H, Liu KD, Lu JZ, Chai XJ, Wang GF, Yao Z, Qian JM. Zeng ZC, et al. J Cancer Res Clin Oncol. 1993;119(5):257-9. doi: 10.1007/BF01212721. J Cancer Res Clin Oncol. 1993. PMID: 8382704 Clinical Trial.

4

Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials.

Zeng ZC, Tang ZY, Liu KD, Lu JZ, Xie H, Yao Z. Zeng ZC, et al. J Cancer Res Clin Oncol. 1998;124(5):275-80. doi: 10.1007/s004320050166. J Cancer Res Clin Oncol. 1998. PMID: 9645459 Clinical Trial.

5

Phase I clinical trial of oral furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study.

Zeng ZC, Tang ZY, Wu ZQ, Ma ZC, Fan J, Qin LX, Zhou J, Wang JH, Wang BL, Zhong CS. Zeng ZC, et al. Am J Clin Oncol. 2000 Oct;23(5):449-54. doi: 10.1097/00000421-200010000-00004. Am J Clin Oncol. 2000. PMID: 11039502 Clinical Trial.

6

DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Zeng ZC, Jiang GL, Wang GM, Tang ZY, Curran WJ, Iliakis G. Zeng ZC, et al. World J Gastroenterol. 2002 Oct;8(5):797-803. doi: 10.3748/wjg.v8.i5.797. World J Gastroenterol. 2002. PMID: 12378618 Free PMC article.

7

Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.

Zeng ZC, Tang ZY, Yang BH, Liu KD, Wu ZQ, Fan J, Qin LX, Sun HC, Zhou J, Jiang GL. Zeng ZC, et al. Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1657-68. doi: 10.1007/s00259-002-0996-x. Epub 2002 Oct 3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12458401

8

Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial.

Zeng ZC, Tang ZY, Yang BH, Fan J, Qin LX, Jiang GL, Zhou J, Sun HC, Cheng JM, Wang JH. Zeng ZC, et al. Hepatogastroenterology. 2004 Jan-Feb;51(55):201-7. Hepatogastroenterology. 2004. PMID: 15011864 Clinical Trial.

9

A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.

Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Yu Y, Wang JH, Guo W. Zeng ZC, et al. Cancer J. 2004 Sep-Oct;10(5):307-16. doi: 10.1097/00130404-200409000-00008. Cancer J. 2004. PMID: 15530260

10

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.

Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ. Zeng ZC, et al. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):432-43. doi: 10.1016/j.ijrobp.2004.05.025. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters